[{"address1": "1240 Deming Way", "city": "Madison", "state": "WI", "zip": "53717-1954", "country": "United States", "phone": "608 824 2800", "fax": "608 824 2996", "website": "https://www.accuray.com", "industry": "Medical Devices", "industryKey": "medical-devices", "industryDisp": "Medical Devices", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. It offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.", "fullTimeEmployees": 987, "companyOfficers": [{"maxAge": 1, "name": "Ms. Suzanne  Winter M.B.A.", "age": 60, "title": "President, CEO & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 807553, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ali  Pervaiz", "age": 43, "title": "Senior VP & CFO, Interim Principal Accounting officer", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 487349, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael  Hoge", "age": 56, "title": "Senior Vice President of Global Operations", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 445629, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jesse  Chew", "age": 42, "title": "Senior VP, Chief Legal Officer & Company Secretary", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 500192, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sandeep  Chalke", "age": 57, "title": "Senior VP & Chief Commercial Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 504986, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John M. Dunn", "title": "Senior VP, Chief Information & Security Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Beth  Kaplan", "title": "Public Relations Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Melanie  Rivers", "title": "Senior VP, Chief Human Resources Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Dennison", "title": "Senior VP, Chief Quality & Development Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Seth  Blacksburg M.B.A., M.D.", "title": "Senior VP & Chief Medical Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 1, "compensationRisk": 4, "shareHolderRightsRisk": 5, "overallRisk": 4, "governanceEpochDate": 1730419200, "compensationAsOfEpochDate": 1735603200, "irWebsite": "http://investors.accuray.com/phoenix.zhtml?c=177244&p=irol-irhome", "maxAge": 86400, "priceHint": 4, "previousClose": 2.09, "open": 2.05, "dayLow": 2.015, "dayHigh": 2.15, "regularMarketPreviousClose": 2.09, "regularMarketOpen": 2.05, "regularMarketDayLow": 2.015, "regularMarketDayHigh": 2.15, "beta": 1.404, "forwardPE": 17.916668, "volume": 770303, "regularMarketVolume": 770303, "averageVolume": 932662, "averageVolume10days": 737860, "averageDailyVolume10Day": 737860, "bid": 2.1, "ask": 2.17, "bidSize": 400, "askSize": 500, "marketCap": 215589104, "fiftyTwoWeekLow": 1.4, "fiftyTwoWeekHigh": 3.05, "priceToSalesTrailing12Months": 0.48533806, "fiftyDayAverage": 1.885, "twoHundredDayAverage": 2.055, "currency": "USD", "enterpriseValue": 299252800, "profitMargins": -0.03721, "floatShares": 97377105, "sharesOutstanding": 100274000, "sharesShort": 4022903, "sharesShortPriorMonth": 4071991, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0401, "heldPercentInsiders": 0.02873, "heldPercentInstitutions": 0.60695, "shortRatio": 5.94, "shortPercentOfFloat": 0.041100003, "impliedSharesOutstanding": 100274000, "bookValue": 0.45, "priceToBook": 4.777778, "lastFiscalYearEnd": 1719705600, "nextFiscalYearEnd": 1751241600, "mostRecentQuarter": 1625011200, "netIncomeToCommon": -16530000, "trailingEps": -0.16, "forwardEps": 0.12, "pegRatio": 0.41, "enterpriseToRevenue": 0.674, "enterpriseToEbitda": 61.575, "52WeekChange": -0.15686274, "SandP52WeekChange": 0.35905516, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "ARAY", "underlyingSymbol": "ARAY", "shortName": "Accuray Incorporated", "longName": "Accuray Incorporated", "firstTradeDateEpochUtc": 1170945000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "64cb6c33-f544-31fe-a9fb-15146526be36", "messageBoardId": "finmb_739115", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.15, "targetHighPrice": 7.0, "targetLowPrice": 5.5, "targetMeanPrice": 6.13, "targetMedianPrice": 6.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 116369000, "totalCashPerShare": 1.157, "ebitda": 4860000, "totalDebt": 199407008, "quickRatio": 0.753, "currentRatio": 1.633, "totalRevenue": 444204000, "debtToEquity": 289.667, "revenuePerShare": 4.478, "returnOnAssets": -0.00166, "returnOnEquity": -0.34377998, "freeCashflow": -3687875, "operatingCashflow": -10607000, "revenueGrowth": 0.168, "grossMargins": 0.31089002, "ebitdaMargins": 0.0109399995, "operatingMargins": 0.03734, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-11"}]